# Recurrent Idiopathic Cerebral Venous Thrombosis

**Authors:** Melissa Tebaldi, Zackary Anderson, Darion Lago, Keegan Plowman, Carl Ruthman

PMC · DOI: 10.7759/cureus.86167 · Cureus · 2025-06-16

## TL;DR

A woman with beta thalassemia minor experienced recurring cerebral venous thrombosis despite multiple interventions, highlighting the need for better diagnostic and risk stratification tools.

## Contribution

This case report highlights the rare recurrence of clot burden in CVT despite interventions, a phenomenon not previously documented in the literature.

## Key findings

- The patient's intracranial pressure continued to rise despite mechanical thrombectomy and EVD placement.
- Clots reaccumulated after interventions, indicating a possible gap in current treatment strategies.
- No existing tools or measurements can predict or improve outcomes for such CVT cases.

## Abstract

A 40-year-old female with a past medical history of beta thalassemia minor presented to the ED with an intractable headache, nausea, and vomiting. A CT head without IV contrast was performed that was negative for any signs of subarachnoid hemorrhage, or thrombotic etiology. The patient presented 48 hours later and was found to have cerebral venous thrombosis (CVT). She was subsequently taken for mechanical thrombectomy. Despite mechanical thrombectomy, her intracranial pressure (ICP) continued to rise. The patient underwent neurosurgical intervention with placement of external ventricular drain (EVD). Despite EVD placement, pressure continued to rise intracranially. The patient then went for a repeat thrombectomy, which was unsuccessful as clots continued to reaccumulate. No existing tool or measurement can lead to better outcomes regarding CVT cases. It is possible that with improved imaging modalities, early diagnosis is possible with high clinical suspicion, but further data needs to be collected. Per our literature review, there is no existing data regarding reaccumulating of clot burden despite intervention. This case represents the need for a broader discussion about risk stratification to identify quantifiable measures for better patient outcomes.

## Linked entities

- **Diseases:** beta thalassemia minor (MONDO:0019402)

## Full-text entities

- **Diseases:** nausea (MESH:D009325), vomiting (MESH:D014839), thrombotic (MESH:D013927), headache (MESH:D006261), CVT (MESH:D020767), subarachnoid hemorrhage (MESH:D013345), beta thalassemia minor (MESH:D017086)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12270514/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12270514/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12270514/full.md

---
Source: https://tomesphere.com/paper/PMC12270514